PPT-New Drug Update 2016 A Formulary Approach
Author : test | Published Date : 2018-03-11
J Russell May PharmD FASHP Clinical Professor University of Georgia College of Pharmacy Disclosure I do not have nor does any immediate family member have actual
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "New Drug Update 2016 A Formulary Approac..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
New Drug Update 2016 A Formulary Approach: Transcript
J Russell May PharmD FASHP Clinical Professor University of Georgia College of Pharmacy Disclosure I do not have nor does any immediate family member have actual or potential conflict of interest within the last twelve . Clinical Operations Workgroup. Meaningful Use – . Formulary & Benefit. Core Measure. Generate and transmit permissible prescriptions electronically (. eRx. ). Meaningful Use Stage 1:. Core: . Update. Clinical Operations Workgroup Update. Health Information Technology Standards Committee. June 19. th. 2013. Formulary & Benefit Standard. Clinical Operations Workgroup. Health Information Technology Standards Committee. Bureau of Health Care Safety and Quality. Department of Public Health. July 14, 2016. Review of June 2. nd. meeting. Non-Opioid Pain Management List. . Draft Formulary Guidance. Next Steps. Slide . Bureau of Health Care Safety and Quality. Department of Public Health. November 5, . 2015. Slide . 2. Draft Formulary . Opening Remarks. Review of October 15 Meeting. Discussion of Evaluation Criteria. and. Dominic Goodwin, Project Co-ordinator, WA Drug Evaluation Panel. The WA SMF - Vision. To . deliver optimal patient outcomes in an equitable manner through a single list of approved medicines for all WA public hospitals; evaluated, implemented and managed in a . Clinical Operations Workgroup. Meaningful Use – . Formulary & Benefit. Core Measure. Generate and transmit permissible prescriptions electronically (. eRx. ). Meaningful Use Stage 1:. Core: . 2020MEDICARE HAPFormularyList of covered drugs cost tiers and how it all worksHAP Senior Plus HMOHAP Senior Plus HMO-POS HAP Senior Plus PPOHAP Primary Choice Medicare HMO HAP Empowered duals HMO SNP Background. A formulary is a continually updated list of medications and related information, representing the clinical judgement of physicians, pharmacists and other experts in the diagnosis, prophylaxis or treatment of disease and promotion of health. . Unit I. DP-206. (Dr.). Anupriya. . Kapoor. Assistant Professor. School of Pharmaceutical sciences, . CSJMU, Kanpur. Definition. Formulary is a continually revised compilation of pharmaceuticals and some important ancillary information that reflects the current clinical judgement of medical staff. . Yousef Ahmed . Alomi. , Sultan Mohammed Al-. Jarallah. , . Rasha. . Abdelsalam. . Elshenawy. , . Faiz. A . Bahadig. . Rph. ABSTRACT: . Objective: . Formulary management is an integrated patient care process which enables physicians, pharmacists and other healthcare professionals to work together to promote clinically sound cost-effective medication therapy and positive therapeutic outcomes. Effective use of healthcare resources can minimize overall medical costs, improve patient access to more affordable care and provide an improved quality of life. A formulary not only includes a list of medications and medication-associated products but also includes medication-use policies, important ancillary drug information, decision support tools and organizational guidelines. Therefore, in this study, we aimed to provide the guiding principles for the Formulary Management System at Ministry of Health (MOH) hospitals in Saudi Arabia. . Yousef Ahmed . Alomi. , Sultan Mohammed Al-. Jarallah. , . Rasha. . Abdelsalam. . Elshenawy. , . Faiz. A . Bahadig. . Rph. ABSTRACT: . Objective: . Ministry of Health (MOH) hospitals in Saudi Arabia should develop, organize and administer a formulary system that follows the principles to optimize patient care by ensuring access to clinically appropriate, safe and cost-effective medications. This can be achieved through the Pharmacy and Therapeutic Committee’s (PTC) role in the evaluation of hospital’s drug formulary and decision-making. The primary purposes of the PTC are policy development, communication and education and formulary management. Therefore, in this study, we aimed to explore the hospital drug formulary evaluation and decision-making at MOH hospitals in Saudi Arabia. . What are the restrictions? There are some common restrictions on a drug formulary. Step therapy Prior authorization insurance provider before they will pay for your medication. Quantity Limits Wha Background. A formulary is a continually updated list of medications and related information, representing the clinical judgement of physicians, pharmacists and other experts in the diagnosis, prophylaxis or treatment of disease and promotion of health. . Dr. Haider Raheem. Formulary Systems . Background. A formulary is a continually updated list of medications and related information, representing the clinical judgement of physicians, pharmacists and other experts in the diagnosis, prophylaxis or treatment of disease and promotion of health. A formulary includes, but is not limited to, a list of medications and medication-associated products or devices, medication-use policies, important ancillary drug information, decision-support tools, and organizational guidelines..
Download Document
Here is the link to download the presentation.
"New Drug Update 2016 A Formulary Approach"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents